HLB Therapeutics Co.,Ltd. (KOSDAQ: 115450)

HLB Therapeutics Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	15,825	23,709	45,821	99,873	13,930	43,198
Short-Term Investments	20,358	8,644	18,101	560	14,601	4,949
Trading Asset Securities	10,220	-	89.45	134.25	254.64	-
Cash & Short-Term Investments	46,403	32,353	64,012	100,567	28,786	48,147
Cash Growth	6.39%	-49.46%	-36.35%	249.37%	-40.21%	185.67%
Accounts Receivable	7,029	9,497	7,900	6,448	4,391	8,436
Other Receivables	496.88	339.49	625.47	1,442	170.86	109.4
Receivables	7,526	9,837	8,527	8,874	5,617	9,856
Inventory	5,323	5,336	6,455	2,345	3,236	3,310
Prepaid Expenses	547.88	161.96	151.72	133.07	4.45	4.41
Other Current Assets	7,138	2,138	865.59	1,333	216	710
Total Current Assets	66,937	49,825	80,012	113,253	37,859	62,028
Property, Plant & Equipment	12,837	10,068	15,780	9,781	9,162	9,513
Long-Term Investments	45,492	58,608	20,335	3,715	15,382	11,192
Goodwill	5,388	5,388	1,075	382.08	4,826	6,392
Other Intangible Assets	5,237	4,896	4,260	3,925	3,918	4,599
Long-Term Deferred Charges	71,010	69,100	63,472	57,586	50,418	45,428
Other Long-Term Assets	2,864	2,910	2,709	1,070	372.3	366.6
Total Assets	209,766	200,795	187,643	189,711	121,938	139,519
Accounts Payable	6,774	8,183	2,517	1,272	2,877	9,336
Accrued Expenses	853.97	902.2	1,510	1,819	814.93	693.81
Short-Term Debt	1,505	7,436	51,551	50,441	12,949	48,401
Current Portion of Long-Term Debt	-	-	98	-	-	-
Current Portion of Leases	3,887	624.24	297.68	364.54	166.25	177.04
Other Current Liabilities	5,691	9,645	2,655	2,820	1,527	1,500
Total Current Liabilities	18,712	26,791	58,628	56,717	18,335	60,108
Long-Term Debt	19,122	1,840	48	-	-	-
Long-Term Leases	241.06	122.2	136.74	320.7	218.7	190.43
Other Long-Term Liabilities	194.81	194.81	194.81	194.81	194.81	194.81
Total Liabilities	38,637	29,276	59,528	59,672	21,632	63,423
Common Stock	39,625	37,016	15,992	15,668	13,475	12,506
Additional Paid-In Capital	132,292	125,176	97,290	190,850	145,207	106,293
Retained Earnings	-28,202	-4,862	-1,916	-90,644	-73,451	-56,542
Treasury Stock	-676.38	-483.65	-413.53	-413.53	-413.53	-413.53
Comprensive Income & Other	5,096	3,620	5,754	3,219	4,535	2,093
Total Common Equity	148,134	160,466	116,708	118,679	89,354	63,936
Minority Interest	22,995	11,053	11,408	11,360	10,952	12,160
Shareholders' Equity	171,129	171,519	128,116	130,039	100,306	76,096
Total Liabilities & Equity	209,766	200,795	187,643	189,711	121,938	139,519
Total Debt	24,756	10,022	52,131	51,126	13,334	48,769
Net Cash (Debt)	21,647	22,330	11,881	49,441	15,451	-621.61
Net Cash Growth	13.16%	87.95%	-75.97%	219.98%	-	-
Net Cash Per Share	293.47	311.60	183.34	845.81	283.51	-11.93
Filing Date Shares Outstanding	78.91	73.71	32.78	66.47	57.08	52.92
Total Common Shares Outstanding	78.91	73.71	65.57	66.47	57.08	52.92
Working Capital	48,226	23,034	21,384	56,536	19,524	1,920
Book Value Per Share	1877.20	2177.02	1779.98	1785.43	1565.51	1208.13
Tangible Book Value	137,509	150,182	111,372	114,372	80,609	52,944
Tangible Book Value Per Share	1742.56	2037.50	1698.60	1720.63	1412.30	1000.43
Land	4,429	4,429	5,916	4,429	4,429	4,429
Buildings	5,150	5,150	8,467	5,146	5,146	5,146
Machinery	2,375	2,927	10,253	2,737	2,396	2,439
Construction In Progress	-	-	263.3	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.